Immunome Inc
NASDAQ:IMNM

Watchlist Manager

Immunome Inc

NASDAQ:IMNM

Watchlist

Dividends

Price: 9.2 USD -6.03% Market Closed

Market Cap: 800.5m USD

Activate Unlimited Plan
to continue IMNM research

You've reached your weekly stock limit.

14-day money-back guarantee

Have any thoughts about
Immunome Inc?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication
US	Chevron Corp NYSE:CVX	Energy

Add Price Alert

Price Target:

Last Price: 9.2 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching false

Delete

Cancel

IMNM Alert

Immunome Inc

9.2

-0.59 (-6.03%)

52 Week Range	5.56 16.51
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US
	Chevron Corp NYSE:CVX	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Immunome Inc

What unique competitive advantages
does Immunome Inc hold over its rivals?

What risks and challenges
does Immunome Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Immunome Inc.

What unique competitive advantages
does Immunome Inc hold over its rivals?

What risks and challenges
does Immunome Inc face in the near future?

Has there been any significant insider trading activity
in Immunome Inc recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Immunome Inc.

Provide P/S
for Immunome Inc.

Provide P/E
for Immunome Inc.

Provide P/OCF
for Immunome Inc.

Provide P/FCFE
for Immunome Inc.

Provide P/B
for Immunome Inc.

Provide EV/S
for Immunome Inc.

Provide EV/GP
for Immunome Inc.

Provide EV/EBITDA
for Immunome Inc.

Provide EV/EBIT
for Immunome Inc.

Provide EV/OCF
for Immunome Inc.

Provide EV/FCFF
for Immunome Inc.

Provide EV/IC
for Immunome Inc.

Show me price targets
for Immunome Inc made by professional analysts.

What are the Revenue projections
for Immunome Inc?

How accurate were the past Revenue estimates
for Immunome Inc?

What are the Net Income projections
for Immunome Inc?

How accurate were the past Net Income estimates
for Immunome Inc?

What are the EPS projections
for Immunome Inc?

How accurate were the past EPS estimates
for Immunome Inc?

What are the EBIT projections
for Immunome Inc?

How accurate were the past EBIT estimates
for Immunome Inc?

Compare the revenue forecasts
for Immunome Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Immunome Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Immunome Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Immunome Inc compared to its peers.

Compare the P/E ratios
of Immunome Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Immunome Inc with its peers.

Analyze the financial leverage
of Immunome Inc compared to its main competitors.

Show all profitability ratios
for Immunome Inc.

Provide ROE
for Immunome Inc.

Provide ROA
for Immunome Inc.

Provide ROIC
for Immunome Inc.

Provide ROCE
for Immunome Inc.

Provide Gross Margin
for Immunome Inc.

Provide Operating Margin
for Immunome Inc.

Provide Net Margin
for Immunome Inc.

Provide FCF Margin
for Immunome Inc.

Show all solvency ratios
for Immunome Inc.

Provide D/E Ratio
for Immunome Inc.

Provide D/A Ratio
for Immunome Inc.

Provide Interest Coverage Ratio
for Immunome Inc.

Provide Altman Z-Score Ratio
for Immunome Inc.

Provide Quick Ratio
for Immunome Inc.

Provide Current Ratio
for Immunome Inc.

Provide Cash Ratio
for Immunome Inc.

What is the historical Revenue growth
over the last 5 years for Immunome Inc?

What is the historical Net Income growth
over the last 5 years for Immunome Inc?

What is the current Free Cash Flow
of Immunome Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Immunome Inc.

Wall Street Price Targets Revenue Forecast Operating Income Forecast Net Income Forecast See Also

Section:

Wall Street Price Targets

Revenue Forecast

Operating Income Forecast

Net Income Forecast

Wall Street
Price Targets

IMNM Price Targets Summary
Immunome Inc

Wall Street analysts forecast IMNM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMNM is 24.99 USD with a low forecast of 20.2 USD and a high forecast of 39.9 USD.

IMNM Average Forecast

Wall Street Target

24.99 USD

172% Upside

IMNM Highest Forecast

Wall Street Target

39.9 USD

334% Upside

Lowest

Price Target

20.2 USD

120% Upside

Average

Price Target

24.99 USD

172% Upside

Highest

Price Target

39.9 USD

334% Upside

Immunome Inc Competitors:
Price Targets

2480

Beijing Luzhu Biotechnology Co Ltd

38% Upside

CPRX

Catalyst Pharmaceuticals Inc

47% Upside

4587

PeptiDream Inc

120% Upside

BPMC

Blueprint Medicines Corp

0% Downside

2480

Beijing Luzhu Biotechnology Co Ltd

38% Upside

CPRX

Catalyst Pharmaceuticals Inc

47% Upside

4587

PeptiDream Inc

120% Upside

BPMC

Blueprint Medicines Corp

0% Downside

RCUS

Arcus Biosciences Inc

211% Upside

ZEAL

Zealand Pharma A/S

104% Upside

SRZN

Surrozen Inc

298% Upside

CDNA

CareDx Inc

57% Upside

Revenue
Forecast

Revenue Estimate
Immunome Inc

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is 101%.

N/A

Past Growth

101%

Estimated Growth

N/A

Estimates Accuracy

N/A

Average

What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Immunome Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-5%

Average Miss

What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Immunome Inc

N/A

Past Growth

N/A

Estimated Growth

Estimates Accuracy

-86%

Average Miss

What are analyst estimates?

What is IMNM's stock price target?

Price Target
24.99 USD

According to Wall Street analysts, the average 1-year price target for IMNM is 24.99 USD with a low forecast of 20.2 USD and a high forecast of 39.9 USD.

What is Immunome Inc's Revenue forecast?

Projected CAGR
101%

The compound annual growth rate of Immunome Inc's revenue for the next 3 years is 101%.

	Immunome Inc NASDAQ:IMNM	9.2 USD -6.03%
	Hanwha Systems Co Ltd KRX:272210	54 400 KRW 2.64%
L	Lannett Company Inc F:LN5	2.254 EUR
T	Thor Medical ASA OSE:TRMED	2.64 NOK 1.93%
	Kingnet Network Co Ltd SZSE:002517	17.68 CNY 1.2%
	Intel Corp NASDAQ:INTC	20.14 USD -3.03%

	Franklin Covey Co NYSE:FC	22.64 USD -0.26%
	Mohawk Industries Inc NYSE:MHK	101.43 USD -3.19%
	Ardmore Shipping Corp NYSE:ASC	10.19 USD 2.93%
	ASGN Inc NYSE:ASGN	51.6 USD -2.49%
	Skyworks Solutions Inc NASDAQ:SWKS	71.25 USD -1.06%
	Weatherford International PLC NASDAQ:WFRD	53.025 USD 1.06%

	Johnson & Johnson NYSE:JNJ	157.1 USD 0.28%
	Bank of America Corp NYSE:BAC	44.09 USD -1.19%
	Mastercard Inc NYSE:MA	562.03 USD -4.62%
	Salesforce Inc NYSE:CRM	258.4 USD -3.19%
	Abbvie Inc NYSE:ABBV	191.08 USD -0.7%
	Home Depot Inc NYSE:HD	354.66 USD -2.34%

	Arista Networks Inc NYSE:ANET	92.35 USD -3.57%
	Deckers Outdoor Corp NYSE:DECK	101.48 USD -5.78%
	Visa Inc NYSE:V	352.85 USD -4.99%
	Texas Pacific Land Corp NYSE:TPL	1 119.58 USD 2.01%
	KLA Corp NASDAQ:KLAC	867.67 USD -0.84%
	Manhattan Associates Inc NASDAQ:MANH	189.31 USD -1.85%

	Salesforce Inc NYSE:CRM	258.4 USD -3.19%
	Accenture PLC NYSE:ACN	311.71 USD -2.02%
	ServiceNow Inc NYSE:NOW	988.66 USD -1.86%
	Spotify Technology SA NYSE:SPOT	710.85 USD 1.14%
	EOG Resources Inc NYSE:EOG	125.28 USD 3.89%
	Applied Materials Inc NASDAQ:AMAT	170.59 USD -2.52%

Immunome Inc
NASDAQ:IMNM